Strikingly, YTHDF2 recognizes m6A methylation to maintain MYC mRNA stability, thereby promoting the expression of the downstream effector IGFBP3, leading to GBM CSC growth (280). The gene discussed is YTHDF2; the disease is glioblastoma.